Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-02-23 @ 11:34 AM
Study NCT ID:
NCT05515458
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2022-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function
Sponsor:
Chipscreen Biosciences, Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CGZ109
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None